Illumina, Inc. v. BGI Genomics Co., Ltd
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
PUBLIC REDACTED VERSION OF
ILLUMINA INC., et al., APRIL 1, 2021 DISCOVERY ORDER (20- 1465 ECF No. 315, 19-3770 ECF No. 313) Plaintiffs, Case No. 20-cv-01465-WHO (TSH) v. Re: Dkt. Nos. 288, 306
BGI GENOMICS CO., LTD., et al., Case No. 19-cv-03770-WHO (TSH) Defendants. Re: Dkt. No. 303
12 13 The Court held a hearing on March 30, 2021 concerning two joint discovery letter briefs. 14 This order follows. 15 A. Illumina’s Interrogatories 2 and 22 (20-1465 ECF No. 288) 16 In 20-1465 (but not 19-3770), Illumina moves to compel further responses to its 17 interrogatories (“rogs”) 2 and 22. Rog 2 asks Defendants to “Identify all instances in which 18 CoolMPS has been used, distributed, tested, offered for sale, or sold in the United States or 19 abroad, and the circumstances relating to such events, including (without limitation) which 20 Defendant or third party used or distributed CoolMPS, when and where such event occurred, 21 whether such event occurred at the…